
Enveda Raises $311 Million to Push Nature-Derived AI Drugs Into Trials
Enveda raises $311M at a $2B valuation to advance AI drug discovery programs from natural compounds into human trials.

Enveda raises $311M at a $2B valuation to advance AI drug discovery programs from natural compounds into human trials.

StrictlyVC at Disrupt 2026 will examine how venture capital is changing, from IPOs and family offices to LP strategy and AI-driven scaling.

Ema raises $77M to expand enterprise AI agents that automate HR, IT and finance workflows and challenge SaaS and services spend.

TechCrunch’s Founder Summit comes to Boston on November 4 with sessions on fundraising, hiring, product-market fit and AI strategy.

Snorkel AI raises $350M at a $3.5B valuation as demand for training data surges across the AI industry.

Andreessen Horowitz is launching an AI academy in San Francisco with partners like Google, Meta and OpenAI, backed by $42 million.

Disrupt 2026 ticket prices rise Sept. 25. TechCrunch says buyers can save up to $200 and get 50% off a second pass.

Disrupt 2026 exhibitor bookings reopened with a Sept. 30 deadline, giving startups one last chance to secure Expo Hall space in San Francisco.

Nscale’s AI IPO could test Wall Street’s appetite for concentrated customer risk, huge contracts and heavy losses in the AI buildout.

Benchmark Disrupt will feature all five GPs debating where the next breakout startup comes from, as AI reshapes venture capital.